Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation?Tze‐Fan Chao, Shih‐Ann Chen, Tzeng‐Ji Chen et al.|Journal of the American College of Cardiology|2015Cited by 258
Using the CHA2DS2-VASc Score for Refining Stroke Risk Stratification in ‘Low-Risk’ Asian Patients With Atrial FibrillationTze‐Fan Chao, Shih‐Ann Chen, Chia‐Jen Liu et al.|Journal of the American College of Cardiology|2014Cited by 174
Statins, Risk of Diabetes, and Implications on Outcomes in the General PopulationKang-Ling Wang, Chern-En Chiang, Chia‐Jen Liu et al.|Journal of the American College of Cardiology|2012Cited by 129
Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial HemorrhageTze‐Fan Chao, Shih‐Ann Chen, Chia‐Jen Liu et al.|Circulation|2016Cited by 116